The emerging therapy of the medication represents a major development in the care of the condition. Different to existing therapies, tirzepatide impacts dual pathways – the GLP-1 hormone and GIP – resulting in https://tirzepatidepeptide257472.gynoblog.com/40773740/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment